title: MicroRNAs in cardiac hypertrophy: angels or devils.
abstract: MicroRNAs (miRNAs) are short noncoding RNA molecules that can regulate gene expression via affecting mRNA stability or translation efficiency. miRNAs mediate many important cellular processes and emerge as a newly discovered regulator of gene expression. In cardiac hypertrophy, miRNAs expression is aberrantly altered. Some of these miRNAs can promote cardiac hypertrophy, whereas others can inhibit the process. In this review, we summarize the up- and downregulated miRNAs during cardiac hypertrophy and discuss about their roles in cardiac hypertrophy. The studies on miRNAs shed new light on the mechanism of cardiac hypertrophy and suggest that they may be promising therapeutic targets in tackling cardiac hypertrophy.
authors.affiliation: Division of Cardiovascular Research, National Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
authors.forename: Su-Ling
authors.initials: SL
authors.lastname: Ding
authors.forename: Lu-Yu
authors.initials: LY
authors.lastname: Zhou
authors.forename: Pei-Feng
authors.initials: PF
authors.lastname: Li
mesh_terms: D000818:Animals; D006332:Cardiomegaly / Q000209:etiology* / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D005786:Gene Expression Regulation / Q000235:genetics / Q000502:physiology; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D008954:Models, Biological
chemical_list: D035683:MicroRNAs